Sentences with phrase «develop cancer screening tests»

Most cancers are curable if they are detected early, and the researchers are exploring ways to use cancer gene discoveries to develop cancer screening tests to improve cancer survival.

Not exact matches

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 1cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

This new study demonstrated that the test can also be used to identify people with precancerous polyps — a finding that makes it potentially more useful for a screening test, since it may be able to identify cancer risk before the disease actually develops.

A SCREENING test which detects abnormally short proteins may soon be used to determine whether women from families with a history of breast cancer are likely to develop the disease.

For example, when researchers developed a simple urine screening test for neuroblastoma — a childhood cancer that arises in immature nerve cells — officials in Japan launched a public health campaign to screen infants.

Despite being screened with gynaecological smear tests, relatively many women over the age of 60 develop cervical cancer.

The Cancer, Ageing and Somatic Mutation Programme seeks to provide leadership in data aggregation and informatics innovation, developing high - throughput cellular models of cancer for genome - wide functional screens and drug testing, and exploring basic scientific questions about the role somatic mutation plays in clonal evolution, ageing and develoCancer, Ageing and Somatic Mutation Programme seeks to provide leadership in data aggregation and informatics innovation, developing high - throughput cellular models of cancer for genome - wide functional screens and drug testing, and exploring basic scientific questions about the role somatic mutation plays in clonal evolution, ageing and develocancer for genome - wide functional screens and drug testing, and exploring basic scientific questions about the role somatic mutation plays in clonal evolution, ageing and development.

To Detect Colon Cancer, Look in the Mouth Researchers in the Johns Hopkins Hereditary Colorectal Cancer Program, found that people who have a hereditary colon cancer syndrome known as familial adenomatous polyposis (FAP) also have abnormally dense blood vessel growth in the lining of their mouths, so they developed a simple and quick screening test that uses an automated camera - like device to measure the vascular density in the lining of the Cancer, Look in the Mouth Researchers in the Johns Hopkins Hereditary Colorectal Cancer Program, found that people who have a hereditary colon cancer syndrome known as familial adenomatous polyposis (FAP) also have abnormally dense blood vessel growth in the lining of their mouths, so they developed a simple and quick screening test that uses an automated camera - like device to measure the vascular density in the lining of the Cancer Program, found that people who have a hereditary colon cancer syndrome known as familial adenomatous polyposis (FAP) also have abnormally dense blood vessel growth in the lining of their mouths, so they developed a simple and quick screening test that uses an automated camera - like device to measure the vascular density in the lining of the cancer syndrome known as familial adenomatous polyposis (FAP) also have abnormally dense blood vessel growth in the lining of their mouths, so they developed a simple and quick screening test that uses an automated camera - like device to measure the vascular density in the lining of the mouth.

In addition, our investigators have used epigenetic biomarkers to: develop screening tests for cancer; help guide surgeons in removing cancerous tumors; predict drug resistance; and, pinpoint more aggressive cancers.

Cancer Center researchers develop a screening test that detects bladder cancer cells in the Cancer Center researchers develop a screening test that detects bladder cancer cells in the cancer cells in the urine.

The prototype for a noninvasive screening test for cancer is developed by Cancer Center researcancer is developed by Cancer Center researCancer Center researchers.

The Colorectal Cancer Moon Shot team is developing a blood - based diagnostic test to screen for the presence of colorectal cancer in a non-invasive mCancer Moon Shot team is developing a blood - based diagnostic test to screen for the presence of colorectal cancer in a non-invasive mcancer in a non-invasive manner.

Testing for mutations in the BRCA1 or BRCA2 genes can help women learn if they are more likely to develop breast or ovarian cancer, which can lead them to get screened more regularly and take advantage of effective treatments.

Findings from the study, published in the International Journal of Cancer, were used to develop a DNA - based screening test for Haflinger horses.

A urine bladder tumor antigen test has been developed and is an excellent screening test to rule out bladder cancer.

Nielsen et al (Vet Comp Oncol 2012) reported that a cancer screening program for Bernese Mountain dogs, developed in Denmark, consisting of diagnostic imaging (thoracic radiographs, abdominal ultrasound) and blood tests every 6 months beginning at 4 years of age, allowed for early detection of histiocytic cancer in dogs otherwise completely symptom free.